Page last updated: 2024-10-31

mianserin and MS (Multiple Sclerosis)

mianserin has been researched along with MS (Multiple Sclerosis) in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McGuire, JL1
Fridman, V1
Wüthrich, C1
Koralnik, IJ1
Jacobs, D1
Goldstraw, PW1
Hanna, N1
Moyes, HC1

Other Studies

2 other studies available for mianserin and MS (Multiple Sclerosis)

ArticleYear
Progressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MS.
    Journal of neurovirology, 2011, Volume: 17, Issue:5

    Topics: Aged; Brain; CD8-Positive T-Lymphocytes; Female; Humans; JC Virus; Leukoencephalopathy, Progressive

2011
Mianserin and jaundice.
    The New Zealand medical journal, 1983, Nov-23, Volume: 96, Issue:744

    Topics: Adult; Cholestasis; Depression; Dibenzazepines; Female; Humans; Mianserin; Multiple Sclerosis

1983